Meridian Bioscience (VIVO) Tops Q2 EPS by 3c, Beat on Revenues; Reaffirms FY Guidance
Go back to Meridian Bioscience (VIVO) Tops Q2 EPS by 3c, Beat on Revenues; Reaffirms FY Guidance| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 5.54 -0.33 (5.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.87 | 52 Week High | $21.49 | |||
| Open | $5.52 | 52 Week Low | $15.75 | |||
| Day High | $6.04 | P/E | 6.30 | |||
| Day Low | $5.50 | EPS | $0.88 | |||
| Volume | 920,419 | |||||
